MHRA Approves Serplulimab for Extensive-Stage SCLC ...Middle East

News by : (Medscape) -
The MHRA has approved serplulimab, the UK’s first anti-PD-1 antibody for extensive-stage small cell lung cancer, improving survival options for adults. Medscape News UK

Read More Details
Finally We wish PressBee provided you with enough information of ( MHRA Approves Serplulimab for Extensive-Stage SCLC )

Also on site :

Most Viewed News
جديد الاخبار